EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls

Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part I: the role of the infection, Ann. Neurol., 61, 288, 10.1002/ana.21117 Cocco, 2011, Epidemiology of multiple sclerosis in south-western Sardinia, Mult. Scler., 17, 182, 10.1177/1352458511408754 Comabella, 2012, EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy, Mult. Scler., 18, 605, 10.1177/1352458511426816 Cossu, 2012, Are Mycobacterium avium subsp. paratuberculosis and Epstein–Barr virus triggers of multiple sclerosis in Sardinia?, Mult. Scler., 18, 1181, 10.1177/1352458511433430 Gilden, 2005, Infectious causes of multiple sclerosis, Lancet Neurol., 4, 195, 10.1016/S1474-4422(05)01017-3 Lünemann, 2008, EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2, J. Exp. Med., 205, 1763, 10.1084/jem.20072397 Mameli, 2012, Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis, PLoS One, 7, e4499, 10.1371/journal.pone.0044991 Munger, 2011, Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel, Mult. Scler., 17, 1185, 10.1177/1352458511408991 Petersen, 2012, Effects of interferon-beta therapy on elements in antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis, J. Neuroimmunol., 249, 105, 10.1016/j.jneuroim.2012.04.013 Serafini, 2007, Dysregulated. Epstein–Barr virus infection in the multiple sclerosis brain, J. Exp. Med., 204, 2899, 10.1084/jem.20071030